17Beta-hydroxysteroid dehydrogenase type 12 in human breast carcinoma: a prognostic factor via potential regulation of fatty acid synthesis.

MLA

Nagasaki, Shuji, et al. “17Beta-Hydroxysteroid Dehydrogenase Type 12 in Human Breast Carcinoma: A Prognostic Factor via Potential Regulation of Fatty Acid Synthesis.” Cancer Research, vol. 69, no. 4, Feb. 2009, pp. 1392–99. EBSCOhost, https://doi.org/10.1158/0008-5472.CAN-08-0821.

APA

Nagasaki, S., Suzuki, T., Miki, Y., Akahira, J.-I., Kitada, K., Ishida, T., Handa, H., Ohuchi, N., & Sasano, H. (2009). 17Beta-hydroxysteroid dehydrogenase type 12 in human breast carcinoma: a prognostic factor via potential regulation of fatty acid synthesis. Cancer Research, 69(4), 1392–1399. https://doi.org/10.1158/0008-5472.CAN-08-0821

Chicago

Nagasaki, Shuji, Takashi Suzuki, Yasuhiro Miki, Jun-Ichi Akahira, Kunio Kitada, Takanori Ishida, Hiroshi Handa, Noriaki Ohuchi, and Hironobu Sasano. 2009. “17Beta-Hydroxysteroid Dehydrogenase Type 12 in Human Breast Carcinoma: A Prognostic Factor via Potential Regulation of Fatty Acid Synthesis.” Cancer Research 69 (4): 1392–99. doi:10.1158/0008-5472.CAN-08-0821.